The article reviews an evaluation of AlphaFold3 on antibody and nanobody complexes. It reports an improvement over AlphaFold2-Multimer, while emphasizing that high-accuracy docking remained difficult and many tested complexes were not accurately predicted.
The authors highlight CDR H3 geometry as a major contributor to complex accuracy. AlphaFold3 showed promise for predicting this loop in bound and unbound settings, but performance on the complete antibody-antigen docking task left room for improvement.
The post also discusses Chai-1 residue-distance restraints as a way to encode epitope information. In the cited evaluation, adding these constraints raised antibody-antigen prediction accuracy, illustrating how experimental or prior site knowledge can guide a model.
These results are framed as benchmark observations rather than certainty for a new target. The article points readers toward model comparisons and confidential hosted workflows for practical structure-prediction campaigns.